These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3346871)

  • 1. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
    Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
    Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
    J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
    Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
    J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
    Hsieh KH; LaHann TR; Speth RC
    J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of residues 2 (arginine) and 6 (histidine) in high-affinity angiotensin II antagonists.
    Samanen J; Brandeis E; Narindray D; Adams W; Cash T; Yellin T; Regoli D
    J Med Chem; 1988 Apr; 31(4):737-41. PubMed ID: 3351849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational restriction of angiotensin II: cyclic analogues having high potency.
    Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
    J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent angiotensin II antagonists with non-beta-branched amino acids in position 5.
    Samanen J; Narindray D; Cash T; Brandeis E; Adams W; Yellin T; Eggleston D; DeBrosse C; Regoli D
    J Med Chem; 1989 Feb; 32(2):466-72. PubMed ID: 2913307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
    Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
    J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
    Goghari MH; Franklin KJ; Moore GJ
    J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac effects of angiotensin antagonists in normotensive rats.
    Sen S; Tarazi RC; Bumpus FM
    Clin Sci (Lond); 1979 May; 56(5):439-43. PubMed ID: 157829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of position 4 in angiotensin II antagonism: a structure-activity study.
    Samanen J; Cash T; Narindray D; Brandeis E; Yellin T; Regoli D
    J Med Chem; 1989 Jun; 32(6):1366-70. PubMed ID: 2724307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cyclic analogs of angiotensin II with cyclization between positions 5 and 7: conformational and biological implications.
    Zhang WJ; Nikiforovich GV; Pérodin J; Richard DE; Escher E; Marshall GR
    J Med Chem; 1996 Jul; 39(14):2738-44. PubMed ID: 8709104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
    Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
    Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the pressor response to angiotensins I and II in the bullfrog, Rana catesbeiana.
    Harper RA; Stephens GA
    Gen Comp Endocrinol; 1985 Nov; 60(2):227-35. PubMed ID: 3905501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of angiotensin II antagonists upon aldosterone production by isolated adrenal glomerulosa cells.
    Saltman S; Fredlund P; Catt KJ
    Endocrinology; 1976 Apr; 98(4):894-903. PubMed ID: 1278097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of angiotensin II antagonists with variations in position 5.
    Nyéki O; Szalay KS; Kisfaludy L; Kárpáti E; Szporny L; Makara GB; Varga B
    J Med Chem; 1987 Oct; 30(10):1719-24. PubMed ID: 3656348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two angiotensin II analogues in normal subjects and hypertensive patients.
    Hata T; Ogihara T; Mikami H; Nakamaru M; Maruyama A; Mandai T; Kumahara Y
    Endocrinol Jpn; 1978 Oct; 25(5):447-52. PubMed ID: 744170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
    Moore GJ; Ganter RC; Goghari MH; Franklin KJ
    Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
    Escher EH; Guillemette G
    J Med Chem; 1979 Sep; 22(9):1047-50. PubMed ID: 226704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.